Arne Astrup
Danish physician and physiologist (born 1955)
Biography
Arne Vernon Astrup (born 1 August, in Frederiksberg, 1955) is a Danish nutritionist, chief physician, researcher, author and professor. He is known as a researcher, communicator and author and has published more than 950 scientific articles. In 2018 he was internationally recognised as Highly Cited Researcher by Clarivate Analytics, a distinction awarded to researchers whose papers rank in the top 1 percent by citations for their field and publication year. In 2024 he received the American Society for Nutrition's George Bray Outstanding Scientific Achievements Award in Obesity Research, which recognises a significant lifetime contribution to the field.
Astrup's research group developed and validated methods for assessing appetite and food intake in humans, including visual analogue scales for subjective appetite sensations. In 1998, a study carried out at the Research Department of Human Nutrition at the Royal Veterinary and Agricultural University in collaboration with Jens Juul Holst of the University of Copenhagen reported that intravenous infusion of GLP-1 increased satiety and reduced food intake in healthy men, and concluded that GLP-1 may play a physiological role in regulating appetite and energy intake in humans. An independent review of GLP-1 research cites the study as early human evidence that GLP-1 reduces appetite and food intake, a finding linked to the later development of GLP-1 receptor agonists for obesity.
Astrup was also a named co-inventor, with Holst and four other named inventors, on a 1996 patent application filed by Novo Nordisk concerning the use of GLP-1 peptides to suppress appetite or induce satiety. He has described this research as part of the scientific rationale for later GLP-1-based obesity medicines, including Novo Nordisk's semaglutide products marketed as Ozempic and Wegovy.
From 1990 to 2020 he was head of the Department of Nutrition, Exercise and Sports at the Faculty of Science at the University of Copenhagen. In the fall of 2016, the department was ranked by the internationally recognised Shanghai Ranking as the world's leading research environment in its field. From 2020 to 2025 he was Senior Vice President, a, Obesity and Nutritional Sciences, at the Novo Nordisk Foundation. He left the foundation on 1 August 2025. Since then he has been an independent consultant and a board member of several international companies, including Eolo Pharma. He was also a member of the board of the Centre for Childhood Health, to which he was appointed by the Novo Nordisk Foundation. He is a senior consultant at Copenhagen University Hospital – Bispebjerg and Frederiksberg, where he was earlier chief consultant at the unit for clinical nutrition research.
Source: Wikipedia (CC BY-SA 4.0). Read the full article
Advertisement
Career highlights
Career & roles
- full professor
Employers / organisations
- University of Copenhagen
- Novo Nordisk Foundation
Awards & honours (1)
- Knight of the 1st Class of the Order of the Dannebrog
Quick answers about Arne Astrup
- How old is Arne Astrup?
- Arne Astrup is 71 years old (born August 1, 1955).
- When is Arne Astrup's birthday?
- Arne Astrup was born on August 1, 1955.
- Where was Arne Astrup born?
- Arne Astrup was born in Frederiksberg.
- What is Arne Astrup's zodiac sign?
- Arne Astrup's zodiac sign is Leo.
- What is Arne Astrup's nationality?
- Arne Astrup is a citizen of Kingdom of Denmark.
- What does Arne Astrup do?
- Arne Astrup is known as writer, physician, scientist, endocrinologist.